Quoin Pharmaceuticals, Ltd. (QNRX)

NASDAQ: QNRX · IEX Real-Time Price · USD

0.620

-0.044 (-6.70%)

At close: Jul 19, 2024, 4:00 PM

0.638

+0.018 (2.90%)

Pre-market: Jul 22, 2024, 7:35 AM EDT

Quoin Pharmaceuticals Income Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2013
Selling, General & Admin	6	6.07	6.58	4.5	1.43	1.51	Upgrade
Research & Development	3.06	3.31	2.67	1.56	0.24	0.05	Upgrade
Operating Expenses	9.06	9.38	9.26	6.06	1.67	1.56	Upgrade
Operating Income	-9.06	-9.38	-9.26	-6.06	-1.67	-1.56	Upgrade
Interest Expense / Income	0	0	0.71	1.37	0.05	0	Upgrade
Other Expense / Income	-0.65	-0.69	-0.59	14.03	0.38	-	Upgrade
Pretax Income	-8.41	-8.69	-9.38	-21.46	-2.1	-1.56	Upgrade
Net Income	-8.41	-8.69	-9.38	-21.46	-2.1	-1.56	Upgrade
Shares Outstanding (Basic)	4	1	0	26	20	20	Upgrade
Shares Outstanding (Diluted)	-	-	-	26	20	20	Upgrade
Shares Change	273.37%	144.43%	-98.47%	31.42%	-	928242.65%	Upgrade
EPS (Basic)	-	-	-	-600.00	-41999.99	-31199.99	Upgrade
EPS (Diluted)	-	-	-	-600.00	-41999.99	-31199.99	Upgrade
Free Cash Flow	-7.55	-7.86	-8.73	-6.35	-1.46	-1.3	Upgrade
Free Cash Flow Per Share	-2.05	-7.97	-21.62	-0.24	-0.07	-0.07	Upgrade
EBITDA	-8.31	-8.58	-8.56	-19.99	-1.94	-1.54	Upgrade
Depreciation & Amortization	0.1	0.1	0.1	0.1	0.1	0.02	Upgrade
EBIT	-8.41	-8.69	-8.67	-20.1	-2.05	-1.56	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).